中文|EN

Technology

Location: home >  Technology >  Technical Platform Overview

Technical Platform Overview

Jiabo technology platform is committed to the research in the field of perioperative anesthesia and injection drug delivery system. Qingyuan pharmaceutical microemulsion delivery system engineering technology research and development center, Guangdong intravenous fat emulsion Engineering Technology Research Center, Guangdong postdoctoral innovation practice base, Guangdong Enterprise Technology Center, Guangdong doctoral workstation and national postdoctoral workstation (sub stations) have been successively established. It has a R & D team of 90 people, and has introduced Qingyuan intravenous fat emulsion research and innovation team, Yangfan plan lipid drug delivery system core technology and industrialization team, and Dr. caitingwei, who returned from overseas and graduated from Ohio State University in pharmaceutical chemistry, providing a good foundation for scientific research and innovation.

In recent years, Jiabo technology platform has made fruitful achievements in research and development projects, approved production approvals and patents. In 2012, entrusted by the drug regulatory department, it drafted and formulated the national quality standard for propofol injection. The company's main products "propofol emulsion injection", "propofol medium / long chain fat emulsion injection", "ropivacaine hydrochloride injection" and "methoxyamine hydrochloride injection" are recognized as high-tech products. The company has successively won the 16th National Patent Excellence Award, the first prize of Qingyuan science and technology progress award, the third prize of Guangdong science and technology award, the first prize of "innovation Qingyuan" science and Technology Award in 2021, and the Guangdong "May Day Labor Award" in 2021.


  • Perioperative Platform

  • Emulsion Platform

  • Liposomes Platform